LD Micro Main Event Archives - Page 87 of 88

TuesdayDec 06, 2016 12:30 pm

Hemispherx Biopharma (HEB) Starts Presentation at LD Micro Main Event

Hemispherx Biopharma (NYSE: HEB) is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. The company's flagship products include Alferon N Injection® and the experimental therapeutics Rintatolimod (tradenames Ampligen® or Rintamod®) and Alferon® LDO. Rintatolimod is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system, including Chronic Fatigue Syndrome. Hemispherx's platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. For more information, visit the company's website at www.hemispherx.net. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayDec 06, 2016 12:00 pm

Spotlight Innovation (STLT) Starts Presentation at LD Micro Main Event

Spotlight Innovation (OTC: STLT) identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. To find and evaluate unique opportunities, the company leverages its extensive relationships with leading scientists, academic institutions and other sources. Spotlight Innovation provides value-added development capability to accelerate development progress. For more information, visit the company's website at www.spotlightinnovation.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of…

TuesdayDec 06, 2016 12:00 pm

Issuer Direct (ISDR) Starts Presentation at LD Micro Main Event

Issuer Direct (NYSE: ISDR) is a tech company that provides disclosure management solutions, shareholder communications tools, and cloud-based compliance technologies. The company offers products and services that enable businesses to produce and distribute their financial and business communications online and in print. It also provides disclosure management system, a cloud-based business process reporting and automation solution that enables users the ability to disclose, manage, and communicate their respective messages from its enterprise platform. For more information, visit the company website at www.issuerdirect.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of…

TuesdayDec 06, 2016 12:00 pm

Onconova Therapeutics (ONTX) Starts Presentation at LD Micro Main Event

Onconova Therapeutics (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, the company has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in clinical trials and several active pre-clinical programs. Advanced clinical trials with its lead compound, rigosertib, are aimed at unmet medical needs of patients with myelodysplastic syndromes (MDS). For more information, visit the company's website at www.onconova.com.…

TuesdayDec 06, 2016 12:00 pm

Advanced Medical Isotope (ADMD) Starts Presentation at LD Micro Main Event

Advanced Medical Isotope (OTC: ADMD) is a late-stage development company primarily engaged in the development of brachytherapy devices for therapeutic applications. The company's focus is on transitioning to full operations upon receipt, if any, of FDA clearance for its patented brachytherapy cancer products. Brachytherapy uses radiation to destroy cancerous tumors by placing a radioactive isotope inside or next to the treatment area. For more information, visit the company's website at www.isotopeworld.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company…

TuesdayDec 06, 2016 12:00 pm

inTEST (INTT) Starts Presentation at LD Micro Main Event

inTEST (NYSE: INTT) is an independent designer, manufacturer and marketer of temperature management products and ATE interface solutions, which are used by semiconductor manufacturers to perform final testing of integrated circuits (ICs) and wafers. The company's high-performance products are designed to enable semiconductor manufacturers to improve the speed, reliability, efficiency and profitability of IC test processes. The inTEST products are also sold into the automotive, consumer electronics, defense/aerospace, energy and telecommunications industries. For more information, visit the company website at www.intest.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social…

TuesdayDec 06, 2016 11:30 am

PixarBio (PXRB) Starts Presentation at LD Micro Main Event

PixarBio (OTC: PXRB) is a specialty pharmaceutical company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain. The company researches and develops targeted delivery systems for drugs, cells, or biologics to treat pain, epilepsy, Parkinson's disease, and spinal cord injury. The company's lead product platform, NeuroRelease, is an extended drug release microparticle platform that is non-opiate, non-addictive for post-surgical pain treatment. In pre-clinical models, NeuroRelease has the potential to achieve six months of sustained therapeutic release of non-opiate drugs for post-operative, acute and chronic pain. For more information, visit the company's website at www.pixarbio.com.…

TuesdayDec 06, 2016 11:30 am

Ur-Energy (URG) Starts Presentation at LD Micro Main Event

Ur-Energy (NYSE: URG) is engaged in uranium mining, recovery and processing activities, including the acquisition, exploration, development and operation of uranium mineral properties in the United States. The company operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming. The Lost Creek processing facility has a nameplate design capacity of 2 million pounds per year. Ur-Energy has also commenced the submission of applications for permits and licenses to operate at its Shirley Basin Project. The company's corporate office is located in Littleton, Colorado, while its registered office is in Ottawa, Ontario. For more information, visit the company's website at…

TuesdayDec 06, 2016 11:30 am

Oculus Innovative Sciences (OCLS) Starts Presentation at LD Micro Main Event

Oculus Innovative Sciences (NASDAQ: OCLS) designs, produces and markets prescription and over-the-counter products based on its Microcyn platform technology for the dermatology, surgical, advanced tissue, skincare and animal healthcare markets. The company's Microcyn platform technology is based on electrically charged oxychlorine small molecules, which are designed to target a range of pathogens that cause disease, including viruses, fungi, spores, and bacteria, such as antibiotic-resistant strains. Oculus' Microcyn has received 14 510(k) clearances for use as a medical device in tissue care management consisting of acute and chronic wounds, and in dermatology applications. For more information, visit the company's website at…

TuesdayDec 06, 2016 11:30 am

Orion Energy Systems (OESX) Starts Presentation at LD Micro Main Event

Orion Energy Systems (NASDAQ: OESX) is engaged in the transformation of commercial and industrial buildings to state-of-the-art energy efficient lighting systems and retrofit lighting solutions. The company manufactures and markets a cutting-edge portfolio of products encompassing LED solid-state lighting and high intensity fluorescent lighting. Many of Orion's nearly 100 granted patents and pending patent applications relate to lighting systems that provide exceptional optical and thermal performance, which drive financial, environmental, and work-space benefits for a wide variety of customers in the retrofit markets. For more information, visit the company's website at www.orionlighting.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and…